ID19520A - Formulasi-formulasi aerosol untuk pengobatan yang mengandung formoterol - Google Patents

Formulasi-formulasi aerosol untuk pengobatan yang mengandung formoterol

Info

Publication number
ID19520A
ID19520A IDP971970A ID971970A ID19520A ID 19520 A ID19520 A ID 19520A ID P971970 A IDP971970 A ID P971970A ID 971970 A ID971970 A ID 971970A ID 19520 A ID19520 A ID 19520A
Authority
ID
Indonesia
Prior art keywords
aerosol formulations
treatment containing
containing formoterol
formoterol
treatment
Prior art date
Application number
IDP971970A
Other languages
English (en)
Indonesian (id)
Inventor
Martin J Oliver
Philip A Jinks
Simon G Paling
Sukhbinder K Jaiswal
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID19520(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of ID19520A publication Critical patent/ID19520A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP971970A 1996-06-11 1997-06-09 Formulasi-formulasi aerosol untuk pengobatan yang mengandung formoterol ID19520A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations

Publications (1)

Publication Number Publication Date
ID19520A true ID19520A (id) 1998-07-16

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971970A ID19520A (id) 1996-06-11 1997-06-09 Formulasi-formulasi aerosol untuk pengobatan yang mengandung formoterol

Country Status (16)

Country Link
EP (2) EP0934057B1 (2)
JP (1) JP5000793B2 (2)
AR (1) AR009231A1 (2)
AT (1) ATE275940T1 (2)
AU (1) AU726382B2 (2)
CA (1) CA2257841C (2)
DE (1) DE69730723T2 (2)
DK (1) DK0934057T3 (2)
ES (1) ES2229366T3 (2)
GB (1) GB9612297D0 (2)
ID (1) ID19520A (2)
NO (1) NO320403B1 (2)
NZ (1) NZ333202A (2)
PT (1) PT934057E (2)
WO (1) WO1997047286A1 (2)
ZA (1) ZA974546B (2)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
HRP20010255A2 (en) * 1998-10-17 2002-04-30 Boehringer Ingelheim Pharma Storable active substance concentrate with formoterol
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
SE0004750D0 (sv) 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
DK1542904T3 (da) 2002-08-27 2008-04-21 Schering Corp Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser
EP1635845A1 (en) * 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
KR20060106823A (ko) * 2003-10-20 2006-10-12 쉐링 코포레이션 약제학적 에어로졸 조성물
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
PL2077830T3 (pl) * 2006-10-17 2013-04-30 Lithera Inc Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej
MX337126B (es) 2009-05-29 2016-02-12 Pearl Therapeutics Inc Administracion respiratoria de agentes activos.
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
RS53514B1 (sr) 2009-10-02 2015-02-27 Chiesi Farmaceutici S.P.A. Farmaceutske aerosolne formulacije od formoterola i beklometazon dipropionata
KR102391332B1 (ko) 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05508616A (ja) * 1989-02-23 1993-12-02 ローヌー　プーラン　ローラー　インターナショナル（ホウルディングス）インコーポレイテッド 治療用エアロゾル剤
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ZA924164B (en) * 1991-06-10 1993-02-24 Schering Corp Non-chlorofluorocarbon aerosol formulations
HUT67445A (en) * 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2-tetrafluorethane
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
EP0617610B1 (en) * 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
AU3373997A (en) 1998-01-07
NO320403B1 (no) 2005-11-28
ZA974546B (en) 1998-11-23
DE69730723T2 (de) 2005-10-06
NO985720D0 (no) 1998-12-07
JP5000793B2 (ja) 2012-08-15
JP2000513340A (ja) 2000-10-10
PT934057E (pt) 2004-12-31
NZ333202A (en) 2000-06-23
AR009231A1 (es) 2000-04-12
ES2229366T3 (es) 2005-04-16
EP0934057B1 (en) 2004-09-15
GB9612297D0 (en) 1996-08-14
EP1400239A1 (en) 2004-03-24
CA2257841C (en) 2008-05-20
AU726382B2 (en) 2000-11-02
CA2257841A1 (en) 1997-12-18
DK0934057T3 (da) 2005-01-24
NO985720L (no) 1999-02-11
DE69730723D1 (de) 2004-10-21
EP0934057A1 (en) 1999-08-11
WO1997047286A1 (en) 1997-12-18
ATE275940T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
ID19520A (id) Formulasi-formulasi aerosol untuk pengobatan yang mengandung formoterol
ATE236617T1 (de) Aerosol-arzneiformulierungen
EP0689767A3 (en) Disinfectant formulations for the skin
ZA975883B (en) High dose liposomal aerosol formulations
BR9509873A (pt) Formulações parasiticidas adequadas para aplicação dérmica
EE9900031A (et) Tramadooli mitmikühikulised preparaadid
ID22523A (id) Formulasi aerosol obat yang mengandung budesonida
FI955042A7 (fi) Syklosporiinia sisältävä jauhemainen koostumus
GB9408117D0 (en) Pharmaceutical formulations
IT1289581B1 (it) Miscela,composizione per la protezione delle piante contenente la miscela e suo impiego
GB9610341D0 (en) Formulation for inhalation
ITMI941169A0 (it) Formulazioni farmaceutiche
NO991430L (no) Insektfordrivende formuleringer
ID19472A (id) Formulasi perbaikan baru untuk pengobatan tromboembolisme
GB9413542D0 (en) Pharmaceutical formulations
SE9404469D0 (sv) Aerosol formulations
DK0784481T3 (da) Sårhelingsformuleringer indeholdende humant plasmafibronektin
FI965187L (fi) 3-fenyyli-3-hydroksipiperidiinejä sisältäviä terapeuttisia koostumuksia
ZA976038B (en) Medicinal aerosol solution formulation
IT1284509B1 (it) Composizioni farmaceutiche effervescenti contenenti metansolfoanilidi
IT1288113B1 (it) Composizioni farmaceutiche effervescenti contenenti sobrerolo
TW314770U (en) Packet structure for the tincture of iodine
SE9502452D0 (sv) Aerosol formulations
GB9408163D0 (en) Pharmaceutical formulations
GB9408151D0 (en) Pharmaceutical formulations